Recent developments in endoscopic ultrasound-guided radiofrequency ablation for pancreatic lesions

Jae Hee Cho, Sung Ill Jang, Dong Ki Lee

Research output: Contribution to journalReview articlepeer-review

3 Citations (Scopus)


Radiofrequency ablation (RFA) has been regarded as an established technique to treat various diseases such as hepatocellular carcinoma, renal cell carcinoma and Barret's esophagus. Although the application of RFA in the pancreas has been limited due to increased risk of adverse events, endoscopic ultrasound-guided RFA (EUS-RFA) has generated interest as a novel minimally invasive treatment modality which combines real-time visualization with a precise localization of the treatment procedure. For over a decade, the optimization of RFA devices have made EUS-RFA relatively safe, and several studies have supported its feasibility. However, there is insufficient evidence to suggest the appropriate indications and to describe long-term outcomes of EUS-RFA for various pancreatic neoplasms such as pancreatic neuroendocrine tumor, ductal adenocarcinoma, and cystic lesions. Therefore, this review focuses on the technical aspects and clinical applications of EUS-RFA for each pancreatic disease.

Original languageEnglish
Pages (from-to)170-176
Number of pages7
JournalInternational Journal of Gastrointestinal Intervention
Issue number4
Publication statusPublished - 2020 Oct

Bibliographical note

Publisher Copyright:
© 2020, Society of Gastrointestinal Intervention.

All Science Journal Classification (ASJC) codes

  • Gastroenterology
  • Hepatology
  • Oncology
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Recent developments in endoscopic ultrasound-guided radiofrequency ablation for pancreatic lesions'. Together they form a unique fingerprint.

Cite this